A Potent Autophagy Inhibitor (Lys05) Enhances the Impact of Ionizing Radiation on Human Lung Cancer Cells H1299

. 2019 Nov 23 ; 20 (23) : . [epub] 20191123

Jazyk angličtina Země Švýcarsko Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid31771188

Grantová podpora
Q40/06 and Q40/09 PROGRES
P50 CA174523 NCI NIH HHS - United States
P30 CA016520 NCI NIH HHS - United States
P01 CA114046 NCI NIH HHS - United States
SV/FVZ201501 Ministry of Defence of the Czech Republic and Ministry of Education, Youth and Sports of the Czech Republic

Autophagy inhibition through small-molecule inhibitors is one of the approaches to increase the efficiency of radiotherapy in oncological patients. A new inhibitor-Lys05-with the potential to accumulate within lysosomes and to block autophagy was discovered a few years ago. Several studies have addressed its chemosensitizing effects but nothing is known about its impact in the context of ionizing radiation (IR). To describe its role in radiosensitization, we employed radioresistant human non-small cell lung carcinoma cells (H1299, p53-negative). Combined treatment of H1299 cells by Lys05 together with IR decreased cell survival in the clonogenic assay and real-time monitoring of cell growth more than either Lys05 or IR alone. Immunodetection of LC3 and p62/SQSTM1 indicated that autophagy was inhibited, which correlated with increased SQSTM1 and decreased BNIP3 gene expression determined by qRT-PCR. Fluorescence microscopy and flow cytometry uncovered an accumulation of lysosomes. Similarly, transmission electron microscopy demonstrated the accumulation of autophagosomes confirming the ability of Lys05 to potentiate autophagy inhibition in H1299 cells. We report here for the first time that Lys05 could be utilized in combination with IR as a promising future strategy in the eradication of lung cancer cells.

Zobrazit více v PubMed

Farhat F.S., Houhou W. Targeted therapies in non-small cell lung carcinoma: What have we achieved so far? Ther. Adv. Med. Oncol. 2013;5:249–270. doi: 10.1177/1758834013492001. PubMed DOI PMC

Yu L., Shang Z.-F., Hsu F.-M., Zhang Z., Tumati V., Lin Y.-F., Chen B.P.C., Saha D. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor. Oncotarget. 2015;6:3848–3860. doi: 10.18632/oncotarget.2975. PubMed DOI PMC

Levine B., Klionsky D.J. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev. Cell. 2004;6:463–477. doi: 10.1016/S1534-5807(04)00099-1. PubMed DOI

Ondrej M., Cechakova L., Durisova K., Pejchal J., Tichy A. To live or let die: Unclear task of autophagy in the radiosensitization battle. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2016;119:265–275. doi: 10.1016/j.radonc.2016.02.028. PubMed DOI

McAfee Q., Zhang Z., Samanta A., Levi S.M., Ma X.-H., Piao S., Lynch J.P., Uehara T., Sepulveda A.R., Davis L.E., et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc. Natl. Acad. Sci. USA. 2012;109:8253–8258. doi: 10.1073/pnas.1118193109. PubMed DOI PMC

Yamamoto A., Tagawa Y., Yoshimori T., Moriyama Y., Masaki R., Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 1998;23:33–42. doi: 10.1247/csf.23.33. PubMed DOI

Shao S., Li S., Qin Y., Wang X., Yang Y., Bai H., Zhou L., Zhao C., Wang C. Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia. Int. J. Oncol. 2014;44:1661–1668. doi: 10.3892/ijo.2014.2313. PubMed DOI PMC

Horie R., Nakamura O., Yamagami Y., Mori M., Nishimura H., Fukuoka N., Yamamoto T. Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells. Int. J. Oncol. 2016;48:37–44. doi: 10.3892/ijo.2015.3227. PubMed DOI PMC

Park J.M., Tougeron D., Huang S., Okamoto K., Sinicrope F.A. Beclin 1 and UVRAG confer protection from radiation-induced DNA damage and maintain centrosome stability in colorectal cancer cells. PLoS ONE. 2014;9:e100819. PubMed PMC

Dowling C.M., Herranz Ors C., Kiely P.A. Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. Biosci. Rep. 2014;34:e00126. doi: 10.1042/BSR20140031. PubMed DOI PMC

Limame R., Wouters A., Pauwels B., Fransen E., Peeters M., Lardon F., De Wever O., Pauwels P. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS ONE. 2012;7:e46536. doi: 10.1371/journal.pone.0046536. PubMed DOI PMC

Chou T.-C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440–446. doi: 10.1158/0008-5472.CAN-09-1947. PubMed DOI

Hernández J.L., Padilla L., Dakhel S., Coll T., Hervas R., Adan J., Masa M., Mitjans F., Martinez J.M., Coma S., et al. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. PLoS ONE. 2013;8:e72480. doi: 10.1371/journal.pone.0072480. PubMed DOI PMC

Mizushima N., Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3:542–545. doi: 10.4161/auto.4600. PubMed DOI

Bjørkøy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005;171:603–614. doi: 10.1083/jcb.200507002. PubMed DOI PMC

Zhang J., Zhang C., Jiang X., Li L., Zhang D., Tang D., Yan T., Zhang Q., Yuan H., Jia J., et al. Involvement of autophagy in hypoxia-BNIP3 signaling to promote epidermal keratinocyte migration. Cell Death Dis. 2019;10:234. doi: 10.1038/s41419-019-1473-9. PubMed DOI PMC

Manic G., Obrist F., Kroemer G., Vitale I., Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Mol. Cell. Oncol. 2014;1:e29911. doi: 10.4161/mco.29911. PubMed DOI PMC

Toulany M., Mihatsch J., Holler M., Chaachouay H., Rodemann H.P. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2014;111:228–236. doi: 10.1016/j.radonc.2014.04.001. PubMed DOI

Karagounis I.V., Kalamida D., Mitrakas A., Pouliliou S., Liousia M.V., Giatromanolaki A., Koukourakis M.I. Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy. Br. J. Cancer. 2016;115:312–321. doi: 10.1038/bjc.2016.202. PubMed DOI PMC

Amaravadi R.K., Winkler J.D. Lys05: A new lysosomal autophagy inhibitor. Autophagy. 2012;8:1383–1384. doi: 10.4161/auto.20958. PubMed DOI PMC

Koukourakis M.I., Kalamida D., Mitrakas A., Pouliliou S., Kalamida S., Sivridis E., Giatromanolaki A. Intensified autophagy compromises the efficacy of radiotherapy against prostate cancer. Biochem. Biophys. Res. Commun. 2015;461:268–274. doi: 10.1016/j.bbrc.2015.04.014. PubMed DOI

Cheng G., Kong D., Hou X., Liang B., He M., Liang N., Ma S., Liu X. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis. Cancer Biother. Radiopharm. 2013;28:153–159. doi: 10.1089/cbr.2012.1297. PubMed DOI PMC

Apel A., Herr I., Schwarz H., Rodemann H.P., Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008;68:1485–1494. doi: 10.1158/0008-5472.CAN-07-0562. PubMed DOI

Hanna R.A., Quinsay M.N., Orogo A.M., Giang K., Rikka S., Gustafsson Å.B. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem. 2012;287:19094–19104. doi: 10.1074/jbc.M111.322933. PubMed DOI PMC

Huang Z., Ye B., Dai Z., Wu X., Lu Z., Shan P., Huang W. Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenation-induced myocytes. Mol. Med. Rep. 2015;11:4678–4684. doi: 10.3892/mmr.2015.3322. PubMed DOI

Tanida I. Autophagy basics. Microbiol. Immunol. 2011;55:1–11. doi: 10.1111/j.1348-0421.2010.00271.x. PubMed DOI

Tanida I., Minematsu-Ikeguchi N., Ueno T., Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1:84–91. doi: 10.4161/auto.1.2.1697. PubMed DOI

Mizushima N., Yamamoto A., Hatano M., Kobayashi Y., Kabeya Y., Suzuki K., Tokuhisa T., Ohsumi Y., Yoshimori T. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 2001;152:657–668. doi: 10.1083/jcb.152.4.657. PubMed DOI PMC

Mizushima N., Ohsumi Y., Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct. Funct. 2002;27:421–429. doi: 10.1247/csf.27.421. PubMed DOI

Makowska A., Eble M., Prescher K., Hoß M., Kontny U. Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy. PLoS ONE. 2016;11:e0166766. doi: 10.1371/journal.pone.0166766. PubMed DOI PMC

Lu S., Sung T., Lin N., Abraham R.T., Jessen B.A. Lysosomal adaptation: How cells respond to lysosomotropic compounds. PLoS ONE. 2017;12:e0173771. doi: 10.1371/journal.pone.0173771. PubMed DOI PMC

Chikte S., Panchal N., Warnes G. Use of LysoTracker dyes: A flow cytometric study of autophagy. Cytom. Part. J. Int. Soc. Anal. Cytol. 2014;85:169–178. doi: 10.1002/cyto.a.22312. PubMed DOI

Gade T.P.F., Tucker E., Nakazawa M.S., Hunt S.J., Wong W., Krock B., Weber C.N., Nadolski G.J., Clark T.W.I., Soulen M.C., et al. Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma. Radiology. 2017;283:702–710. doi: 10.1148/radiol.2017160728. PubMed DOI PMC

Ndoye A., Budina-Kolomets A., Kugel C.H., Webster M.R., Kaur A., Behera R., Rebecca V.W., Li L., Brafford P.A., Liu Q., et al. ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma. Cancer Res. 2017;77:5873–5885. doi: 10.1158/0008-5472.CAN-17-0907. PubMed DOI PMC

DeVorkin L., Hattersley M., Kim P., Ries J., Spowart J., Anglesio M.S., Levi S.M., Huntsman D.G., Amaravadi R.K., Winkler J.D., et al. Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma. Mol. Cancer Res. MCR. 2017;15:250–258. doi: 10.1158/1541-7786.MCR-16-0132. PubMed DOI PMC

Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace